Mass spectrometry and imaging technologies in Geroscience
老年科学中的质谱和成像技术
基本信息
- 批准号:7647091
- 负责人:
- 金额:$ 87.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-09-30 至 2012-06-30
- 项目状态:已结题
- 来源:
- 关键词:AgingAntibodiesAreaBioenergeticsBiological AssayCellsCoupledDevelopmentDisease modelDrug Delivery SystemsExperimental DesignsImageImaging technologyInstitutesInstitutionMass Spectrum AnalysisMeasurementMicroscopicNeuronsOxidation-ReductionPharmaceutical PreparationsPost-Translational Protein ProcessingPrincipal InvestigatorProtein AnalysisProtein ChemistryProteinsProteomicsRadialResearch PersonnelServicesStagingTechnologyWorkage relatedassay developmentbasecellular imagingfluorophoreinstrumentinstrumentationranpirnaseresearch studysmall molecule
项目摘要
The 'Mass Spectrometry and Imaging Technologies in Geroscience1 P30 Core will consist of an integrated
suite of mass spectrometry and microscopic imaging technologies coupled to specific protein and small
molecule drug and metabolite analysis assays and bioenergetic analysis. The aims of this P30 Core are to
integrate the unique instrumentation facilities at the Buck Institute in imaging and mass spectrometry to
target the needs of the 10 components of the U54 in structural and functional proteomics, and for the
analysis of drugs and targeted metabolites that constitute this Geroscience initiative. Specifically, the
imaging and mass spectrometry technologies will encompass; (i) functional and fixed-cell imaging using
protein-specific fluorophores and antibodies, (ii) functional analysis of intact neurons and other cells including
bioenergetic and redox measurements, (iii) development and implementation of protein chemistries, (iv)
mass spectrometry-based analysis of proteins, including their identification, quantitation, interactions and
posttranslational modifications, (v) mass spectrometry imaging and profiling studies, and (vi) drug and
metabolite analyses. These studies will be carried out on a range of aging and aging-related disease models
that constitute the components of this U54. The P30 core will consist of two main but integrated parts:
'Functional and Structural Imaging Technologies' directed by Dr. Nicholls and 'Mass Spectrometry
Technologies' directed by the principal investigator, Dr. Bradford Gibson. We propose to apply and integrate
these instrument-based technologies at the very earliest stages of experimental design and work closely with
the other investigators to develop, optimize, and implement these mass spectrometry and imaging
technologies.
“质谱和成像技术在Geroscience1 P30核心将包括一个集成的
一套质谱和显微成像技术,结合特定的蛋白质和小
分子药物和代谢物分析测定和生物能量分析。P30核心的目标是
将巴克研究所独特的成像和质谱仪器设备整合起来,
目标是U54的10个组分在结构和功能蛋白质组学中的需求,以及
分析药物和目标代谢物,构成这一Geroscience倡议。具体而言是
成像和质谱技术将包括:(i)功能和固定细胞成像,
蛋白质特异性荧光团和抗体,(ii)完整神经元和其它细胞的功能分析,
生物能量和氧化还原测量,(iii)蛋白质化学的开发和实施,(iv)
基于质谱的蛋白质分析,包括它们的鉴定、定量、相互作用和
翻译后修饰,(v)质谱成像和分析研究,和(vi)药物和
代谢物分析。这些研究将在一系列衰老和衰老相关疾病模型上进行
构成了U54的组成部分P30核心将由两个主要但集成的部分组成:
由Nicholls博士指导的“功能和结构成像技术”和“质谱法”
由首席研究员布拉德福德吉布森博士指导的技术。我们建议应用并整合
这些基于仪器的技术在实验设计的最早阶段,
其他研究人员开发,优化和实施这些质谱和成像
技术.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bradford Wayne Gibson其他文献
Bradford Wayne Gibson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bradford Wayne Gibson', 18)}}的其他基金
TripleTOF 5600 High Resolution Mass Spectrometer
TripleTOF 5600 高分辨率质谱仪
- 批准号:
8447837 - 财政年份:2013
- 资助金额:
$ 87.63万 - 项目类别:
BioAnalytical Chemistry Core B: Innate reponses to microbial infection
生物分析化学核心 B:对微生物感染的先天反应
- 批准号:
8305639 - 财政年份:2011
- 资助金额:
$ 87.63万 - 项目类别:
AB SCIEX QTRAP 5500 LC MS/MS system
AB SCIEX QTRAP 5500 LC MS/MS 系统
- 批准号:
7794815 - 财政年份:2010
- 资助金额:
$ 87.63万 - 项目类别:
BioAnalytical Chemistry Core B: Innate reponses to microbial infection
生物分析化学核心 B:对微生物感染的先天反应
- 批准号:
7920685 - 财政年份:2010
- 资助金额:
$ 87.63万 - 项目类别:
Mass spectrometry and imaging technologies in Geroscience
老年科学中的质谱和成像技术
- 批准号:
8142537 - 财政年份:2007
- 资助金额:
$ 87.63万 - 项目类别:
Mass spectrometry and imaging technologies in Geroscience
老年科学中的质谱和成像技术
- 批准号:
8097305 - 财政年份:2007
- 资助金额:
$ 87.63万 - 项目类别:
QSTAR Elite Quadrupole-o-TOF LC/MS/MS System
QSTAR Elite 四极杆-o-TOF LC/MS/MS 系统
- 批准号:
7389246 - 财政年份:2007
- 资助金额:
$ 87.63万 - 项目类别:
Mass spectrometry and imaging technologies in Geroscience
老年科学中的质谱和成像技术
- 批准号:
7502168 - 财政年份:2007
- 资助金额:
$ 87.63万 - 项目类别:
Mass spectrometry and imaging technologies in Geroscience
老年科学中的质谱和成像技术
- 批准号:
7898683 - 财政年份:2007
- 资助金额:
$ 87.63万 - 项目类别:
Mass spectrometry and imaging technologies in Geroscience
老年科学中的质谱和成像技术
- 批准号:
8130352 - 财政年份:2007
- 资助金额:
$ 87.63万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 87.63万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 87.63万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 87.63万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 87.63万 - 项目类别:
Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 87.63万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 87.63万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 87.63万 - 项目类别:
Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
- 批准号:
10699504 - 财政年份:2023
- 资助金额:
$ 87.63万 - 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 87.63万 - 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
- 批准号:
10782567 - 财政年份:2023
- 资助金额:
$ 87.63万 - 项目类别: